Dr. James Braun, Neurosciences Pharmacy Clinical Specialist at SSM Health St. Louis, and Dr. Kyle Hoelting, Senior Manager of Drug Information at Vizient, continue to share their insights on the use of TNK vs Alteplase for treating acute ischemic stroke. They also discuss the nuances of this therapeutic area and share recent work from an expert panel led by Vizient.

Guest speakers: James Braun, PharmD, BCCCP Neurosciences Pharmacy Clinical Specialist SSM Health

Kyle Hoelting, PharmD, BCPS Senior Manager of Drug Information Vizient

Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence

Show Notes:

[00:30-3:59] Medication safety risks associated with thrombolytics

[04:00-4:42] Using one drug over another

[04:43-6:48] How frontline pharmacy staff can utilize this information

[06:49-11:44] What Vizient can add to the discussion

[11:45-11:55] When report will be released

Links | Resources:

Tenecteplase vs alteplase in acute ischemic stroke: Vizient expert panel

Verified Rx: Evidenced based medicine Click here

Verified Rx: Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes Click here

Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 1 Click here

Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 2 Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed